Historical record - last NADAC effective date: 5/20/2015
Product Information
ROBITUSSIN COUGH-COLD CF LIQ is a brand product labeled by Haleon US Holdings LLC, priced at $0.0372 per ML under NDC 00031871612. Its NADAC has been published 97 times since Nov 28, 2013.
ROBITUSSIN COUGH-COLD CF LIQ
dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochlorideStrength
5; 50; 2.5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Haleon US Holdings LLCNDC
00031871612
Classification
Brand
Dosage Form
LIQUID
Route
ORAL
Effective Date
5/20/2015
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001On Market Since
9/1/2009
Pharmacological Classes
Price Statistics
The NADAC for ROBITUSSIN COUGH-COLD CF LIQ has been published 97 times since Nov 28, 2013, and over the history we have for it it has risen 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0372 per ML |
|---|---|
| All-time high | $0.0385 (May 13, 2015) |
| All-time low | $0.0350 (Dec 17, 2014) |
| Median price | $0.0370 |
| Average price | $0.0365 |
| Largest weekly change | +6.1% (Feb 18, 2015) |
| Weeks tracked | 97 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+4.1%
Last surveyed Sep 30, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROBITUSSIN COUGH-COLD CF LIQ?
The current National Average Drug Acquisition Cost (NADAC) for ROBITUSSIN COUGH-COLD CF LIQ, manufactured by Haleon US Holdings LLC, is $0.0372 per ML (NDC 00031871612), effective Sep 30, 2015.
How has the price of ROBITUSSIN COUGH-COLD CF LIQ changed over time?
Over the history we have for it, the NADAC for ROBITUSSIN COUGH-COLD CF LIQ has risen 4.1%. It has been tracked across 97 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROBITUSSIN COUGH-COLD CF LIQ?
Since Nov 28, 2013, the NADAC for ROBITUSSIN COUGH-COLD CF LIQ has ranged from a low of $0.0350 (Dec 17, 2014) to a high of $0.0385 (May 13, 2015), with a median of $0.0370 per ML.
Are there cheaper alternatives to ROBITUSSIN COUGH-COLD CF LIQ?
No other NADAC-published product currently shares the active ingredient and strength of ROBITUSSIN COUGH-COLD CF LIQ in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROBITUSSIN COUGH-COLD CF LIQ?
ROBITUSSIN COUGH-COLD CF LIQ (NDC 00031871612) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.